Post implementation evaluation – Medicare Benefits Schedule (MBS) usage data assessment

Australian Genomics will conduct a post-implementation evaluation of the usage of different MBS item numbers for genomic testing in rare disease (e.g. childhood syndromes, renal, cardiac, mitochondrial, deafness) to understand laboratory implementation, uptake among different professional groups, jurisdictional variations and costs. We will systematically identify barriers and enablers to adoption. This work will inform strategies to support implementation of existing MBS item numbers as well as the development and assessment of future applications, including associated reanalysis items.